The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva
Open accessPublished version of a preprint
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of an ongoing pandemic that has infected over 36 million and killed over 1 million people. Informed implementation of government public health policies depends on accurate data on SARS-CoV-2 immunity at a population scale. We hypothesized that detection of SARS-CoV-2 salivary antibodies could serve as a noninvasive alternative to serological testing for monitoring of SARS-CoV-2 infection and seropositivity at a population scale.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876 · cited 1×
“Previous studies suggest that antibody responses are elevated among individuals with severe infection (18, 19, 29).”
BackgroundAntibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769 · cited 4×
“Ten SARS-CoV-2 antigens were obtained commercially or from collaborators at Icahn School of Medicine at Mount Sinai ( Table 1 ).”
BackgroundInfluentialOkba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614
Premkumar, L., Segovia-Chumbez, B., Jadi, R., Martinez, D. R., Raut, R., Markmann, A. J., Cornaby, C., Bartelt, L., Weiss, S., Park, Y., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc8413 · Cited by 868 · cited 1×
“Ultimately, it does not appear that cross-reactivity from other hCoVs will be a confounding issue in detecting SARS-CoV-2-specific antibodies in humans (15, 28).”
Self-citationMental health services for older adults in China during the COVID-19 outbreak
Yang, Y., Li, W., Zhang, Q., Zhang, L., Cheung, T., & Xiang, Y.-T. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30079-1 · Cited by 857
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Isho, B., Abe, K. T., Zuo, M., Jamal, A. J., Rathod, B., Wang, J. H., Li, Z., Chao, G., Rojas, O. L., Bang, Y. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abe5511 · Cited by 822 · cited 3×
“improved, perhaps by optimizing sample dilutions or by optimizing other assay parameters (8, 9).”
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Chandrashekar, A., Liu, J., Martinot, A. J., McMahan, K., Mercado, N. B., Peter, L., Tostanoski, L. H., Yu, J., Maliga, Z., Nekorchuk, M., et al. (2020) · Science · doi:10.1126/science.abc4776 · Cited by 816
Altered mental status as a novel initial clinical presentation for COVID-19 infection in the elderly
Ward, C. F., Figiel, G. S., & McDonald, W. M. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.05.013 · Cited by 54
Research works printed but not linked: 24
- 10.1001/jama.2020.7872 · DOI
- Gronvall G, Connel N, Kobokovich A, West R, Warmbrod K, Shearer M, Mullen L, Inglesby T. 2020. Developing a national strategy for serology (antibody testing) in the United States. John Hopkins Bloomberg School of Public Health, Baltimore, MD.
- 10.15585/mmwr.mm6918e3 · DOI · Paper page
- 10.1136/bmj.m1052 · DOI · Paper page
- 10.1007/978-3-030-35784-9_13 · DOI
- 10.1056/NEJMc2016359 · DOI · Paper page
- 10.1016/j.cca.2020.09.018 · DOI
- 10.1093/infdis/jiy638 · DOI
- 10.1016/j.jim.2017.04.012 · doi:10.1016/j.jim.2017.04.012
- 10.3402/jom.v5i0.20401 · DOI · Paper page
- 10.1196/annals.1384.012 · DOI · Paper page
- 10.1093/aje/kwh107 · doi:10.1093/aje/kwh107
- 10.1097/QAD.0000000000000896 · DOI
- CDC. 2020. CDC 2019-novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel. CDC, Atlanta, GA.
- Cervia C Nilsson J Zurbuchen Y Valaperti A Schreiner J Wolfensberger A Raeber ME Adamo S Emmenegger M Hasler S Bosshard PP De Cecco E Bächli E Rudiger A Stüssi-Helbling M Huber LC Zinkernagel AS Schaer DJ Aguzzi A Held U Probst-Müller E Rampini SK Boyman O. 2020. Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19. bioRxiv 2020.05.21.108308. doi:10.1101/2020.05.21.108308. · DOI
- 10.1093/cid/ciaa310 · DOI · Paper page
- 10.1016/S2666-5247(20)30120-8 · DOI · Paper page
- 10.1038/s41587-020-0659-0 · DOI · Paper page
- Adams ER Ainsworth M Anand R Andersson MI Auckland K Baillie JK Barnes E Beer S Bell JI Berry T Bibi S Carroll M Chinnakannan SK Clutterbuck E Cornall RJ Crook DW De Silva T Dejnirattisai W Dingle KE Dold C Espinosa A Eyre DW Farmer H Fernandez Mendoza M Georgiou D Hoosdally SJ Hunter AA Jeffrey K Klenerman P Knight J Knowles C Kwok AJ Leuschner U Levin R Liu C Lopez-Camacho C Martinez Garrido JC Matthews PC McGivern H Mentzer AJ Milton J Mongkolsapaya J Moore SC Oliveira MS Pereira F Perez Lopez E Peto T Ploeg RJ Pollard A Prince T . 2020. Antibody testing for COVID-19: a report from the National COVID Scientific Advisory Panel. medRxiv 2020.04.15.20066407. doi:10.12688/wellcomeopenres.15927.1. · DOI · Paper page
- Lassaunière R Frische A Harboe Z Nielsen AC Fomsgaard A Krogfelt K Jørgensen C. 2020. Evaluation of nine commercial SARS-CoV-2 immunoassays. medRxiv https://doi.org/10.1101/2020.04.09.20056325. · DOI · Paper page
- 10.1080/22221751.2020.1729069 · DOI · Paper page
- 10.1128/CVI.00124-08 · DOI
- 10.1093/infdis/129.3.271 · DOI
- 10.1038/s41591-020-0887-3 · DOI
Cited by
SARS-CoV-2 vaccines in development
Krammer, F. (2020) · Nature · doi:10.1038/s41586-020-2798-3 · Cited by 2,098
Aging in COVID-19: Vulnerability, immunity and intervention
Chen, Y., Klein, S. L., Garibaldi, B. T., Li, H., Wu, C., Osevala, N. M., Li, T., Margolick, J. B., Pawelec, G., & Leng, S. X. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101205 · Cited by 1,007
Self-citationDiagnostics for SARS-CoV-2 infections
Kevadiya, B. D., Machhi, J., Herskovitz, J., Oleynikov, M. D., Blomberg, W. R., Bajwa, N., Soni, D., Das, S., Hasan, M., Patel, M., et al. (2021) · Nature Materials · doi:10.1038/s41563-020-00906-z · Cited by 833
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Isho, B., Abe, K. T., Zuo, M., Jamal, A. J., Rathod, B., Wang, J. H., Li, Z., Chao, G., Rojas, O. L., Bang, Y. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abe5511 · Cited by 822
New-onset IgG autoantibodies in hospitalized patients with COVID-19
Chang, S. E., Feng, A., Meng, W., Apostolidis, S. A., Mack, E., Artandi, M., Barman, L., Bennett, K., Chakraborty, S., Chang, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25509-3 · Cited by 489
Metadata
- Authors
- Pisanic, N., Randad, P. R., Kruczynski, K., Manabe, Y. C., Thomas, D. L., Pekosz, A., Klein, S. L., Betenbaugh, M. J., Clarke, W. A., Laeyendecker, O., Caturegli, P. P., Larman, H. B., Detrick, B., Fairley, J. K., Sherman, A. C., Rouphael, N., Edupuganti, S., Granger, D. A., Granger, S. W., Collins, M. H., & Heaney, C. D.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2020-12-17
- Volume
- 59
- Issue
- 1
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W3093083319
- Cited by
- 250
- References
- 10
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Funders
- HHS | National Institutes of Health (U24OD023382)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R21AI139784, R01AI130066, R43AI141265)
- HHS | NIH | National Institute of Environmental Health Sciences (R01ES026973)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.